Cencora closes $3.0B senior notes offering, proceeds to repay OneOncology acquisition debt

Cencora, Inc.

$500M each of 3.950% notes due 2029, 4.250% notes due 2030, 4.600% notes due 2033, 5.650% notes due 2056; $1.0B of 4.900% notes due 2036.
Net proceeds will repay amounts outstanding under a 364-Day Term Credit Agreement used to fund a portion of the OneOncology acquisition; remainder for general corporate purposes.
Offering closed Feb 13, 2026; joint book-runners: Citigroup, J.P. Morgan, BofA Securities, Wells Fargo.

item 1.01item 2.03item 7.01item 8.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.